ABSTRACT
BACKGROUND: We evaluated the efficacy and toxicity of docetaxel plus cisplatin combination as first-line chemotherapy for advanced gastric cancer. METHODS: Patients with metastatic or recurrent gastric adenocarcinoma, performance score Subject(s)
Humans
, Adenocarcinoma
, Cisplatin
, Drug Therapy
, Drug Therapy, Combination
, Febrile Neutropenia
, Neutropenia
, Stomach Neoplasms